The COVID-19 vaccine from Pfizer/BioNTech has received an emergency authorization in its first market, the UK, following a rapid review of the data by the Medicines and Healthcare products Regulatory Agency. The first vaccinations will be made available to priority recipients starting next week.
The move follows “months of rigorous clinical trials and a thorough analysis of the data by experts at the MHRA...







